Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Women with stage III breast cancer or who are diagnosed with triple-negative or HER2-positive disease may live longer when starting chemotherapy no more than 30 days after surgery, research shows.
According to a study recently published in the Journal of Clinical Oncology, practicing Hatha yoga for as few as 3 months may lessen fatigue and inflammation in people treated for breast cancer.
Exercising often after breast cancer treatment ends may help women improve their quality of life over time, say researchers from the University of Illinois at Urbana-Champaign.
Researchers found the same amount of tumor cells present at surgery among two groups of women receiving therapy for HER2-positive breast cancer. The first group was treated before surgery with trastuzumab (Herceptin) plus paclitaxel (Taxol), followed by anthracycline chemotherapy. The second received the same treatment, but with more trastuzumab given at the same time as the anthracycline. This finding lends support to past studies showing trastuzumab is not needed during anthracycline (e.g., doxorubicin or epirubicin) treatment to shrink or get rid of the cancer before surgery.
Breast cancer death rates among young women have declined over four decades, yet the rate of decrease has been less for young black women. This study also looked at the economic impact of U.S. breast cancer deaths in young women and found they represent a total lifetime productivity loss of $5.5 billion annually.
Women at risk of carrying a BRCA1 or BRCA2 gene mutation who had genetic counseling over the phone benefitted as much as women who had counseling in person, a study found. This finding could mean easier access to the service at a more affordable cost.
Tailored Treatment Based on Response to Early Chemotherapy May Improve Survival in Early-Stage Disease
Researchers who observed whether a tumor shrank after the first few cycles of pre-surgery, or neoadjuvant, chemotherapy made an important observation. They found that when they based further chemotherapy treatment on the tumor’s reaction, outcomes were best for women with hormone receptor-positive breast cancer. These women lived for the longest spans of time without the cancer growing or traveling, compared with women with tumors testing negative for hormones.
Men are more likely than women to undergo mastectomy when diagnosed with breast cancer, a study published in the International Journal of Radiation Oncology • Biology • Physics revealed. The study is the largest to date to focus on treatment and outcomes for men with breast cancer in the United States.
Women with early-stage breast cancer treated with lumpectomy followed by radiation may live longer than those receiving mastectomy alone or with radiation, researchers found.Their study, published in the journal JAMA Surgery, compared the risk of dying from breast cancer over 10 years.
Less financially secure young women who self-detect a breast change are more likely to delay seeking help, according to a recent study.